机构：[1]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.神经内科首都医科大学宣武医院[2]Division of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, 15282, USA.[3]Department of Neurology, University of Pittsburgh, Pittsburgh, PA, 15260, USA.[4]Geriatric Research Education and Clinical Centers, VA Pittsburgh Healthcare System, Pittsburgh, PA, 15240, USA.
出处：
ISSN：
基金：
Chinese Natural Science Fund No. 81441037 (to Y.Z.) and by National Institutes
of Health/NINDS grants NS079345 (to G.C.) and VA Merit Review grants BX002346 and BX003923 (to G.C.).
第一作者机构：[1]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
通讯作者：
通讯机构：[1]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.[3]Department of Neurology, University of Pittsburgh, Pittsburgh, PA, 15260, USA.[4]Geriatric Research Education and Clinical Centers, VA Pittsburgh Healthcare System, Pittsburgh, PA, 15240, USA.
推荐引用方式(GB/T 7714)：
Yan Zhang,Gang Liu,Yuan Wang,et al.Procalcitonin as a Biomarker for Malignant Cerebral Edema in Massive Cerebral Infarction[J].CEREBROVASCULAR DISEASES.2018,45:74.
APA：
Yan Zhang,Gang Liu,Yuan Wang,Yingying Su,Rehana K. Leak&Guodong Cao.(2018).Procalcitonin as a Biomarker for Malignant Cerebral Edema in Massive Cerebral Infarction.CEREBROVASCULAR DISEASES,45,
MLA：
Yan Zhang,et al."Procalcitonin as a Biomarker for Malignant Cerebral Edema in Massive Cerebral Infarction".CEREBROVASCULAR DISEASES 45.(2018):74
